Acknowledgement upfront re NXR being biggest investor which is good.
Had a look at the Kihal corneal article which is one we found and posted about in 2015. Be good to see some further newer articles etc be added in due course.
Decent patent coverage and clear outline of what they have which saves us having to hunt for them.
Outlines WBT as a "R&D company with patent portfolio" so my question would be are they still looking to develop the product in house / sub contract or outsource that side completely via a JV or side agreement?
Nicely marketed to the viewer I feel giving a brief but succint overview of where the tech fits with other solutions as complimentary / enhancement or direct competition.
Overall a positive imo as why create a new website which is essentially a marketing tool in its simplest form, if not going forward?
Obviously, the next keys will be the relationship with NXR developing (or not), an outline where the tech is physically at or a roadmap maybe and at least we can now see how the board will shape up plus any further WBT developments.
Little bit more transparency rather than relying on NXR anns.
I guess the big question now is more around what is NXR doing to relist?
NXR Price at posting:
2.0¢ Sentiment: None Disclosure: Held